Different Induction Response Criteria Do Not Influence 1-Year Response and Remission Rates of Ustekinumab 90 Mg Q8w in Phase III ProgramDominik Naessens, C Gasink, Jewel Johanns|The American Journal of Gastroenterology|2016Cited by 1
A141 DIFFERENT INDUCTION RESPONSE CRITERIA DO NOT INFLUENCE 1 YEAR RESPONSE AND REMISSION RATES OF USTEKINUMAB 90MG Q8W IN PHASE III PROGRAMDominik Naessens, C Gasink, Jewel Johanns|Journal of the Canadian Association of Gastroenterology|2018Cited by 0
748 Ustekinumab Improved Work Productivity in Patients With Moderate to Severe Ulcerative Colitis: Results From the Phase 3 UNIFI Induction and Maintenance StudiesChenglong Han, Bruce E. Sands, Jewel Johanns et al.|The American Journal of Gastroenterology|2019Cited by 0